bigtalan
5 hours ago
Well that was a pretty quick reply from the link I posted yesterday .
Hi XXXX
Hope you are well.
I noticed you recently viewed one of our capital raisings, ResolutionRx, what are your thoughts about the company so far?
Would you be interested in seeing the latest copy of their investor presentation?
As a side note, we are also able to arrange a 1:1 phone / zoom call between you and the management team for ResolutionRx or any of the capital raisings on our Platform to give you an opportunity to conduct further due diligence on the company, their management, and just generally support your research before investing.
If you want to arrange a call with the management team for next week, let me know a time and day that suits you.
Kind Regards,
Andrew Ciantar - Equities Desk Manager
LTListener
21 hours ago
So many irons in the fire for sure.
Short-term (Q4) should be exciting as this is way overdue for an update on the OSA and NIH/gabakine platforms. The ampakine phase 2 SCI getting started is a big deal and I think investors would love to hear expected milestones on this trial and how is connects and parlays into ADHD/other medical indications for this platform. As we've all discussed here, website refresh, publications, collaborations and financing are plenty other items to update stakeholders on as well.
Longer term (2025) this "could" be where the valuations absolutely skyrocket into 100s of millions. IF the phase 2 SCI trial goes very well, there will be ample reason to not only get a phase 3 going, but likely ADHD trials as well. I would think BP/partner interest would be very high at that point. I also think it is likely KRM-ll-81 is in human trials as well judging by all the commentary and preclinical success. Epilepsy and pain mitigation are massive markets and here again I think significant partner interest may be at the door even before a human clinical trial is underway with such a superior candidate.
Hard to say how quickly human trials begin and complete. A majority of my shares are for the long haul 2025 and beyond anyway as I really see ROI exponentially increasing as more and more human trials are underway with this pipeline.
bigtalan
1 day ago
Yes the increase is on one of my accounts that holds 11,640,000 share so this increase shot it up. My avg is.00114 , just wish I was able to buy when it went into EM but I am fine with the 15m I currently have . GLTA
Symbol Change $ Change % Qty # Price Paid $ Day's Gain $ Total Gain $ Total Gain % Value $
RSPI 0.0013 108.33% 11,640,000 0.00114 15,132.00 15,759.70 118.14% 29,100.00